Fig. 4
From: How to prevent viremia rebound? Evidence from a PRRSv data-supported model of immune response

Relative cytokine levels discriminating between uniphasic and biphasic viremia profiles over infection time. Relative cytokine levels discriminating between uniphasic and biphasic viremia profiles over infection time. Percentage of a antiviral cytokines (IFNγ,IFNα,TNFα) among antiviral and immuno-modulatory (IL10,TGFβ) cytokines; b IFNγ and c IFNα among antiviral cytokines; d pro-cellular (IL12,IFNγ) and e pro-humoral (IL4,Pi) cytokines over the pro-cellular, pro-humoral and pro-regulatory (TGFβ) cytokines. Mean value (solid line) and standard deviation (shaded area) of the 35 representative individuals selected for the uniphasic (green) and biphasic (red) profiles; Balanced contribution level (horizontal dashed line). ∗p-value <5% when comparing uniphasic and biphasic profiles (permutation tests over four time periods: 0–10, 11–20, 21–31, 32–42 days)